KSF Investigates Avadel Pharmaceuticals sale to Alkermes plc. Investigating adequacy of price and process.
A probe is underway by Charles C. Foti, Jr., Esq., a former Louisiana Attorney General, and law firm Kahn Swick & Foti, LLC, into the planned acquisition of Avadel Pharmaceuticals plc (NasdaqGM: AVDL) by Alkermes plc (NasdaqGS: ALKS). The transaction details involve significant numbers in the stock market, with AVDL and ALKS on Nasdaq. This investigation is being conducted as of December 12, 2025, in locations including New York and New Orleans.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments